The session will address and discuss the divide between raw accuracy metrics, typically reported for AI medical devices and actual clinical impact metrics we should be focusing on like number of increased/avoided biopsies, number of increased/missed disease detection.
Chairperson's introduction
Anton Becker, New York City / United States
Panel discussion
Benoît Rizk, Villars-Sur-Glane / Switzerland
Christian Blüthgen, Palo Alto / United States
Michail Klontzas, Heraklion / Greece
Jacob Johannes Visser, Rotterdam / Netherlands
Q&A: Numbers don’t lie, but do they misdirect?